ANI PHARMACEUTICALS INC — Director's Dealing 2023

Dec 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2023-12-15

Reporting Person: Shanmugam Muthusamy (Director, HEAD OF R&D, COO-NOVITIUM OPS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-15	Common Stock	S	11974	$52.44	Disposed	970646	Indirect
2023-12-18	Common Stock	S	13026	$52.44	Disposed	957620	Indirect
2023-12-19	Common Stock	S	25000	$52.65	Disposed	932620	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	47407	Direct
Common Stock	5000	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.97 to $52.97, inclusive.

F3: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.02 to $52.97, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.45 to $53.19, inclusive.

F6: The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.